Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
CERENOME, INC. (CNSY)
Activity window: Oct. 20, 2025 to Oct. 19, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 5, 2026 | CORRESP | Neutral/Informational | Moderate | The correspondence from Plus Therapeutics, Inc. to the SEC is a formal request for the acceleration of the effective date for their registration statement on Form S-3, which was f… | Read Filing EDGAR |
| Jun. 4, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated June 4, 2026, informs Plus Therapeutics, Inc. that their registration statement on Form S-3, filed on June 2, 2026, will not be reviewed by the SEC. T… | Read Filing EDGAR |
| Jan. 9, 2026 | CORRESP | Neutral/Informational | Moderate | The correspondence from Lake Street Capital Markets, LLC, on behalf of Plus Therapeutics, Inc., requests the SEC to accelerate the effective date of their Registration Statement o… | Read Filing EDGAR |
| Jan. 9, 2026 | CORRESP | Neutral/Informational | Moderate | Cerenome, Inc. has submitted a request for the acceleration of the effective date of their registration statement on Form S-1, which was filed on January 9, 2026. The company aims… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.